8-K filing — GeoVax Labs, Inc. (GOVX)
Filed: 2026-07-27 AccNo: 0001437749-26-024522 Size: 299 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits
Read original at edgarStocks · News reference
Geovax Labs (NASDAQ:GOVX) reported quarterly losses of $(0.97) per share which beat the analyst consensus estimate of $(2.88) by 66.32 percent. This is a 88.9 percent increase over losses of $(8.74) per share from the
Reference details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Filed: 2026-07-27 AccNo: 0001437749-26-024522 Size: 299 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits
Read original at edgar